The evolving role of immunotherapy in ovarian cancer

Ana Carolina Veneziani, Laura Venegas, Amit M. Oza · 2026

Read The evolving role of immunotherapy in ovarian cancer by Ana Carolina Veneziani, Laura Venegas, Amit M. Oza (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13563111.txt.

Description

Ana Carolina Veneziani, Laura Venegas, and Amit M Oza review immunotherapy for ovarian cancer in a 2026 paper. The disease stays a leading cause of death among women's cancers, and immune drugs that changed care elsewhere have worked weakly here. Tumors vary widely, shut immune cells out, and lack markers that predict who will respond.

Recent work has shifted toward combined and tailored plans: paired immune drugs, mixes with chemotherapy or vessel-blocking drugs, cell therapies, vaccines, and viruses that attack tumors. Gains so far are clearest in one hard-to-treat group when immune drugs join chemotherapy. Marker tests and machine learning may sharpen patient choice. The authors trace a move from trial-and-error care toward plans built on each tumor's biology.

Catalog record

CREATORAna Carolina Veneziani, Laura Venegas, Amit M. Oza
YEAR2026
COLLECTIONPAPERS
FORMATTXT
FILE SIZE60 KB
VERSION1.0
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC13563111

Browse the full library · About the Tower of Babel